Acceso abierto

New-Onset Atrial Fibrillation in the Post-Primary PCI Setting: A Systematic Review


Cite

1. Schmitt J, Duray G, Gersh BJ, Hohnloser SH. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J. 2009;30(9):1038-45.10.1093/eurheartj/ehn57919109347Search in Google Scholar

2. Bloch Thomsen PE, Jons C, Raatikainen MJ, et al. Long-term recording of cardiac arrhythmias with an implantable cardiac monitor in patients with reduced ejection fraction after acute myocardial infarction: the Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) study. Circulation. 2010;122(13):1258-64.10.1161/CIRCULATIONAHA.109.90214820837897Search in Google Scholar

3. Sinno H, Derakhchan K, Libersan D, et al. Atrial ischemia promotes atrial fibrillation in dogs. Circulation. 2003;107(14):1930-6.10.1161/01.CIR.0000058743.15215.0312668526Search in Google Scholar

4. Worme MD, Tan MK, Armstrong DWJ, et al. Previous and New Onset Atrial Fibrillation and Associated Outcomes in Acute Coronary Syndromes (from the Global Registry of Acute Coronary Events). Am J Cardiol. 2018.10.1016/j.amjcard.2018.06.00130115426Search in Google Scholar

5. Jabre P, Roger VL, Murad MH, et al. Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and meta-analysis. Circulation. 2011;123(15):1587-93.10.1161/CIRCULATIONAHA.110.986661308277321464054Search in Google Scholar

6. Gonzalez-Pacheco H, Marquez MF, Arias-Mendoza A, et al. Clinical features and in-hospital mortality associated with different types of atrial fibrillation in patients with acute coronary syndrome with and without ST elevation. J Cardiol. 2015;66(2):148-54.10.1016/j.jjcc.2014.11.00125480145Search in Google Scholar

7. Braga CG, Ramos V, Martins J, et al. Impact of atrial fibrillation type during acute coronary syndromes: Clinical features and prognosis. Rev Port Cardiol. 2015;34(6):403-10.10.1016/j.repc.2015.01.01026028489Search in Google Scholar

8. Neumann F-J, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/ EACTS Guidelines on myocardial revascularization. Eur Heart J. 2018:ehy394-ehy.10.1093/eurheartj/ehy65830403801Search in Google Scholar

9. Jons C, Jacobsen UG, Joergensen RM, et al. The incidence and prognostic significance of new-onset atrial fibrillation in patients with acute myocardial infarction and left ventricular systolic dysfunction: a CARISMA substudy. Heart rhythm. 2011;8(3):342-8.10.1016/j.hrthm.2010.09.09021093611Search in Google Scholar

10. Akdemir R, Ozhan H, Gunduz H, et al. Effect of reperfusion on P-wave duration and P-wave dispersion in acute myocar-dial infarction: primary angioplasty versus thrombolytic therapy. Ann Noninvasive Electrocardiol.. 2005;10(1):35-40.10.1111/j.1542-474X.2005.00595.xSearch in Google Scholar

11. Siu C-W, Jim M-H, Ho H-H, et al. Transient Atrial Fibrillation Complicating Acute Inferior Myocardial Infarction. CHEST. 2007;132(1):44-9.10.1378/chest.06-273317400657Search in Google Scholar

12. Consuegra-Sanchez L, Melgarejo-Moreno A, Galcera-Tomas J, et al. Short- and long-term prognosis of previous and new-onset atrial fibrillation in ST-segment elevation acute myocar-dial infarction. Revista espanola de cardiologia (English ed). 2015;68(1):31-8.10.1016/j.rec.2014.03.01725131442Search in Google Scholar

13. Kinjo K, Sato H, Sato H, et al. Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol. 2003;92(10):1150-4.10.1016/j.amjcard.2003.07.02114609587Search in Google Scholar

14. Lopes RD, Elliott LE, White HD, et al. Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial. Eur Heart J. 2009;30(16):2019-28.10.1093/eurheartj/ehp213276495419502623Search in Google Scholar

15. Lin CJ, Liu CF, Kung CT, Sun CK, Lin YC, Leu S, et al. The prognostic value of atrial fibrillation on 30-day clinical outcome in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Int Heart J. 2011;52(3):153-8.10.1536/ihj.52.15321646737Search in Google Scholar

16. Beukema RJ, Elvan A, Ottervanger JP, et al. Atrial fibrillation after but not before primary angioplasty for ST-segment elevation myocardial infarction of prognostic importance. Neth Heart J.. 2012;20(4):155-60.10.1007/s12471-012-0242-5Search in Google Scholar

17. Asanin M, Stankovic S, Mrdovic I, et al. B-type natriuretic peptide predicts new-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention. Peptides. 2012;35(1):74-7.10.1016/j.peptides.2012.02.02222421508Search in Google Scholar

18. Mrdovic I, Savic L, Krljanac G, et al. Incidence, predictors, and 30-day outcomes of new-onset atrial fibrillation after primary percutaneous coronary intervention: insight into the RISK-PCI trial. Coron artery dis. 2012;23(1):1-8.10.1097/MCA.0b013e32834df55222107800Search in Google Scholar

19. Rene AG, Genereux P, Ezekowitz M, et al. Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial). Am J Cardiol. 2014;113(2):236-42.10.1016/j.amjcard.2013.09.01624176066Search in Google Scholar

20. Gal P, Parlak E, Demirel F, et al. Prognostic significance of incident atrial fibrillation following STEMI depends on the timing of atrial fibrillation. Neth Heart J. 2015;23(9):430-5.10.1007/s12471-015-0709-2454794826021618Search in Google Scholar

21. Zehir R, Tekkesin AI, Haykir N, et al. Peak troponin I level predicts new-onset atrial fibrillation in patients with myocardial infarction. Clin Invest Med.2016;39(6):E213-e9.10.25011/cim.v39i6.2748927917780Search in Google Scholar

22. Karatas MB, Canga Y, Ipek G, et al. Association of admission serum laboratory parameters with new-onset atrial fibrillation after a primary percutaneous coronary intervention. Coron Artery dis. 2016;27(2):128-34.10.1097/MCA.000000000000033326693808Search in Google Scholar

23. Olsen FJ, Pedersen S, Jensen JS, Biering-Sorensen T. Global longitudinal strain predicts incident atrial fibrillation and stroke occurrence after acute myocardial infarction. Medicine. 2016;95(44):e5338.10.1097/MD.0000000000005338559116627858918Search in Google Scholar

24. Garg L, Agrawal S, Agarwal M, et al. Influence of Atrial Fibrillation on Outcomes in Patients Who Underwent Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction. Am J Cardiol. 2017.10.1016/j.amjcard.2017.12.00329394997Search in Google Scholar

25. Hwang KK, Eom SY, Lee SY, et al. Atrial Fibrillation on Admission Is Related With Higher Mortality in ST-Segment Elevation Myocardial Infarction Patients. Inte Heart J. 2017;58(4):486-94.10.1536/ihj.16-28628690292Search in Google Scholar

26. Karabag Y, Rencuzogullari I, Cagdas M, et al. Association between BNP levels and new-onset atrial fibrillation : A propensity score approach. Herz. 2017.10.1007/s00059-017-4598-628707026Search in Google Scholar

27. Topaz G, Flint N, Steinvil A, et al. Long term prognosis of atrial fibrillation in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention. Int J Cardiol. 2017;240:228-33.10.1016/j.ijcard.2017.03.06028390742Search in Google Scholar

28. Podolecki T, Lenarczyk R, Kowalczyk J, et al. Significance of Atrial Fibrillation Complicating ST-Segment Elevation Myocardial Infarction. Am J Cardiol. 2017;120(4):517-21.10.1016/j.amjcard.2017.05.01728645470Search in Google Scholar

29. Rencuzogullari I, Cagdas M, Karakoyun S, et al. Propensity score matching analysis of the impact of Syntax score and Syntax score II on new onset atrial fibrillation development in patients with ST segment elevation myocardial infarction. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc. 2017.10.1111/anec.12504693170328975725Search in Google Scholar

30. Rhyou HI, Park TH, Cho YR, et al. Clinical factors associated with the development of atrial fibrillation in the year following STEMI treated by primary PCI. J Cardiol. 2018;71(2):125-8.10.1016/j.jjcc.2017.08.00428969967Search in Google Scholar

31. Romanov A, Martinek M, Pürerfellner H, et al. Incidence of atrial fibrillation detected by continuous rhythm monitoring after acute myocardial infarction in patients with preserved left ventricular ejection fraction: results of the ARREST study. EP Europace. 2018;20(2):263-70.10.1093/europace/euw34428069838Search in Google Scholar

32. Mazzone A, Scalese M, Paradossi U, et al. Development and validation of a risk stratification score for new-onset atrial fi-brillation in STEMI patients undergoing primary percutaneous coronary intervention. Int J Clin Practice. 2018;72(4):e13087.10.1111/ijcp.1308729665154Search in Google Scholar

33. Modin D, Olsen FJ, Pedersen S, Jensen JS, Biering-Sorensen T. Measures of left atrial function predict incident atrial fibrillation in STEMI patients treated with primary percutaneous coronary intervention. Int J Cardiol. 2018;263:1-6.10.1016/j.ijcard.2018.03.01329754907Search in Google Scholar

34. Asanin MR, Vasiljevic ZM, Matic MD et al. The Long-Term Risk of Stroke in Patients with Acute Myocardial Infarction Complicated with New-Onset Atrial Fibrillation. Clin Cardiol. 2009;32(8):467-70.10.1002/clc.20603665319619685521Search in Google Scholar

35. Zusman O, Amit G, Gilutz H, Zahger D. The significance of new onset atrial fibrillation complicating acute myocardial infarction. Clin Res Cardiol. 2012;101(1):17-22.10.1007/s00392-011-0357-521910032Search in Google Scholar

36. Bishara R, Telman G, Bahouth F, et al. Transient atrial fibrillation and risk of stroke after acute myocardial infarction. Thromb Haemost. 2011;106(5):877-84.10.1160/TH11-05-034321866303Search in Google Scholar

37. Guenancia C, Toucas C, Fauchier L, et al. High rate of recurrence at long-term follow-up after new-onset atrial fibrillation during acute myocardial infarction. Europace: European pacing, arrhythmias, and cardiac electrophysiology: journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2018.10.1093/europace/euy16830060066Search in Google Scholar

38. Chaudhary N, Bundhun PK, Yan H. Comparing the clinical outcomes in patients with atrial fibrillation receiving dual antiplatelet therapy and patients receiving an addition of an anticoagulant after coronary stent implantation: A systematic review and meta-analysis of observational studies. Medicine. 2016;95(50):e5581.10.1097/MD.0000000000005581526803827977592Search in Google Scholar

39. Gibson CM, Mehran R, Bode C, et al. Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI. N Engl J Med. 2016;375(25):2423-34.10.1056/NEJMoa161159427959713Search in Google Scholar

40. Cannon CP, Bhatt DL, Oldgren J, et al. Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation. N Engl J Med2017;377(16):1513-24.10.1056/NEJMoa170845428844193Search in Google Scholar

eISSN:
0324-1750
Idioma:
Inglés
Calendario de la edición:
4 veces al año
Temas de la revista:
Medicine, Basic Medical Science, Immunology, Clinical Medicine, other